ANO1 and colorectal carcinoma: ANO1‐negative cases possessed longer irPFS/irOS than ANO1‐positive cases (Figure 1H), which retained either in GC (with statistical significance/tendency for irPFS/irOS) or nonGC (EC+CRC+other cancers, with statistical tendency) (Figure S1K, Supporting Information).